Quantcast

Latest Vaccines Stories

2014-05-21 04:21:27

BLUE BELL, Pa., May 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. Joseph Kim, President and CEO, will give a corporate presentation at the Jefferies 2014 Global Healthcare Conference taking place June 2-5 at the Grand Hyatt Hotel in New York City. Inovio PresentationMonday, June 2, 20148:00 AM ET A live webcast of Dr. Kim's presentation can be accessed at the following URL: http://wsw.com/webcast/jeff82/INO. An archived version of...

2014-05-19 08:28:56

DUBLIN, May 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/rd8s6p/meningococcal) has announced the addition of the "Global Meningococcal Vaccines Market - Forecasts to 2019: Sanofi, Novartis, GlaxoSmithKline, Pfizer, Serum Institute of India, JN-International, Nuron, Baxter and Biomed" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Meningococcal disease caused by the bacterium Neisseria meningitidis is a life...

2014-05-19 08:28:40

Global Target Established: Replikins Identical in Humans and Camels; Anti-Mers-CoV Replikins Vaccine(TM) Available and Testing Has Started LONDON, May 19, 2014 /PRNewswire-USNewswire/ -- In an analysis of the human specimen gene sequences published Saturday, May 17 by PubMed, Bioradar UK, Ltd. found the Replikin gene sequences of the human Mers-CoV specimens in Florida and Indiana to contain identical Replikin gene sequences to those from other countries. These new findings followed BioRadar...

2014-05-19 08:28:22

Results indicate vaccine generates an immune response against key toxins in volunteers and establish dosing for Phase III BOSTON, May 19, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented Phase II trial (H-030-012) results for an investigational vaccine for the prevention of Clostridium difficile (C. diff) infection (CDI) at the 114th General Meeting of the American Society for Microbiology (ASM). The Phase II trial met its...

2014-05-16 12:27:03

Anti-Mers-CoV Synthetic Replikins Vaccine(TM) Available Now to Vaccinate Camels LONDON, May 16, 2014 /PRNewswire/ -- A Replikins analysis by Bioradar, Ltd of Mers-CoV in all isolates of the virus genes reported to date in Pubmed from both humans and camels has revealed specific shared gene Replikin structures that are not just homologous but are identical in the virus genes infecting both camels and humans, and conserved since 2012 in cases from all countries affected. Replikins, Ltd. has...

2014-05-15 12:36:33

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global H1N1 Vaccines Industryhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/global_h1n1_vaccines_industry.html This report analyzes the Global market for H1N1 Vaccines in US$ Million. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. The...

2014-05-15 12:33:41

Public health initiative aims to increase unacceptably low adult vaccination rates PHILADELPHIA, May 15, 2014 /PRNewswire-USNewswire/ -- The American College of Physicians (ACP), CECity, and Pfizer Inc. (NYSE:PFE) have announced a new initiative designed to increase adult immunization rates by assisting physicians and other health care providers in strongly recommending appropriate vaccination and tracking adult immunization rates for quality measurement and improvement. The three...

2014-05-14 08:29:41

DaVita recognized for groundbreaking teammate immunization program DENVER, May 14, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, was recognized at the National Adult and Influenza Immunization Summit (NAIIS) as the national winner in the "Healthcare Personnel Campaign" category of the 2014 Immunization Excellence Awards....

2014-05-13 04:22:33

BLUE BELL, Pa., May 13, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today it acquired worldwide rights (excluding China) for early preclinical therapies addressing Alzheimer's disease and multiple sclerosis based on the academic research of Dr. Bin Wang, a professor at Fudan University's Shanghai Medical College. Dr. Wang is a pioneer in the field of DNA therapies, having worked closely with Dr. David Weiner at the University of Pennsylvania. Dr. Wang was the...

2014-05-12 23:04:56

The 2013 influenza season was the first in which quadrivalent influenza vaccines with an extra B strain were available in the U.S. which helped revenues for flu vaccine makers last year, according to Kalorama Information’s new report, “Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments.” In 2013, influenza vaccines generated $3.1 billion in revenues, up from 2.8 billion in 2012. New York, NY (PRWEB) May 12, 2014 The 2013 influenza season was...


Latest Vaccines Reference Libraries

72_d0e074525de5bb741daf382f8d62213f
2011-04-25 16:38:12

Neisseria meningitidis is a heterotrophic gram-negative diplococcal bacterium best known for its role in meningitis and other forms of meningococcal disease such as meningococcemia. It is a major cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in Africa and in Asia. In the US there are approximately 2500 to 3500 cases of N. meningitides infections. Children under 5 are at a higher risk as well as people in the sub-Saharan...

45_cbb742ff010fcfbfac5b5b73fd2e0254
2011-02-23 17:23:51

Poliovirus, the causative agent of poliomyelitis and a member of the family of Picornaviridae, is a human enterovirus. It is composed of an RNA genome that is a single-stranded positive-sense RNA. It was first isolate in 1909 and was published in 1981. It is one of the most well characterized viruses and has become a useful model system for understanding the biology of RNA viruses. It infects human cells by binding to an immunoglobulin-like receptor on the cell surface. The three...

More Articles (2 articles) »
Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related